Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00282815 · ClinicalTrials.gov registry record · Phase 2

Sleep Apnea Treatment After Stroke (SATS)

A Phase 2 study, sponsored by University of Michigan.

Terminated
Registry status
Phase 2
Development phase
32
Enrollment target

NCT00282815: Clinical Trial Phase 2 study, sponsored by University of Michigan.

NCT00282815 is a Phase 2 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 32 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00282815, a Phase 2 study, was terminated before completion, sponsored by University of Michigan.

TERMINATED
Registry status
Phase 2
Development phase
32 participants
Enrollment target

Study Summary

The purpose of this study is to determine if treating stroke patients who have obstructive sleep apnea with continuous positive airway pressure will improve symptoms caused by the stroke.

Interventions

  • DEVICE sham CPAP
  • DEVICE continuous positive airway pressure or CPAP

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2004-09
Est. Completion 2010-05
Phase Phase 2
University of Michigan

1,327 total trials

Why NCT00282815 stopped before completion

NCT00282815 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower).

The record links to 0 conditions, and to 2 interventions - of which sham CPAP is the first listed.

NCT00282815 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00282815 about?

NCT00282815 is a clinical study titled "Sleep Apnea Treatment After Stroke (SATS)". The purpose of this study is to determine if treating stroke patients who have obstructive sleep apnea with continuous positive airway pressure will improve symptoms caused by the stroke.

What is the current status of trial NCT00282815?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2004-09. Estimated completion is 2010-05.

What interventions are being tested in trial NCT00282815?

The interventions under investigation include: sham CPAP (DEVICE), continuous positive airway pressure or CPAP (DEVICE).

Who is sponsoring clinical trial NCT00282815?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00282815's enrollment target sits among peer trials

32 1563rd of 2000 higher than 423 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00282815, the US trial registry maintained by the National Library of Medicine. NCT00282815 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.